Fact CheckerSign in

NCT02872805Completed

Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study

Source: ClinicalTrials.gov · Last updated 22 Dec 2023

Brief summary (registry, in English)

One of the distinct challenges faced by emerging adults with HIV is the transition of their care from their long-term pediatric HIV provider to treatment within an adult HIV program. The consequences of an unsuccessful transition can range from difficult to catastrophic. The Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study is a prospective cohort trial of an innovative intervention targeting gaps in care that are major drivers of loss in the ART continuum of care cascade among adolescents and increasing missed opportunities to engage adolescents into care.

Status (registry)
Completed
Study type
Interventional
Enrollment
298 (actual)
First submitted
16 Aug 2016
Start date
Nov 2019
Primary completion date
Dec 2023
Lead sponsor
University of Maryland, Baltimore
Diseases
HIV
NCT number
NCT02872805

What you commit to

  • Study type: Interventional
  • Participants enrolled: 298
  • From Nov 2019 to the primary completion date, Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • HIV infected patients who have significant cognitive impairments(e.g., Mental retardation)
  • Patients planning to transition their HIV care outside the selected study facilities

Who the study is looking for

  • HIV infected patients between the ages of 16-19 years of age
  • Patients who have been in care at the study site facility for a minimum of 1 year
  • Patients who plan to transition their HIV care to one of the selected study sites
  • Patients who are able to provide informed consent

Age in the registry: 16 years to 19 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Human Virology, Nigeria
Coordinator of this site? Confirm its status
AbujaNigeriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.